Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1956 4
1957 3
1958 1
1959 1
1962 2
1963 7
1964 6
1965 8
1966 8
1967 14
1968 12
1969 21
1970 13
1971 11
1972 22
1973 16
1974 13
1975 22
1976 13
1977 17
1978 18
1979 26
1980 33
1981 41
1982 43
1983 50
1984 67
1985 83
1986 97
1987 72
1988 83
1989 86
1990 59
1991 70
1992 80
1993 66
1994 72
1995 55
1996 84
1997 84
1998 97
1999 90
2000 112
2001 77
2002 92
2003 92
2004 86
2005 88
2006 91
2007 103
2008 119
2009 108
2010 130
2011 179
2012 149
2013 147
2014 151
2015 144
2016 169
2017 173
2018 184
2019 191
2020 133
Text availability
Article attribute
Article type
Publication date

Search Results

4,100 results
Results by year
Filters applied: . Clear all
Page 1
Clinical Importance of Epstein⁻Barr Virus-Associated Gastric Cancer.
Nishikawa J, Iizasa H, Yoshiyama H, Shimokuri K, Kobayashi Y, Sasaki S, Nakamura M, Yanai H, Sakai K, Suehiro Y, Yamasaki T, Sakaida I. Nishikawa J, et al. Among authors: sakai k. Cancers (Basel). 2018 May 29;10(6):167. doi: 10.3390/cancers10060167. Cancers (Basel). 2018. PMID: 29843478 Free PMC article. Review.
B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
Yonesaka K, Haratani K, Takamura S, Sakai H, Kato R, Takegawa N, Takahama T, Tanaka K, Hayashi H, Takeda M, Kato S, Maenishi O, Sakai K, Chiba Y, Okabe T, Kudo K, Hasegawa Y, Kaneda H, Yamato M, Hirotani K, Miyazawa M, Nishio K, Nakagawa K. Yonesaka K, et al. Among authors: sakai k. Clin Cancer Res. 2018 Jun 1;24(11):2653-2664. doi: 10.1158/1078-0432.CCR-17-2852. Epub 2018 Mar 12. Clin Cancer Res. 2018. PMID: 29530936 Free article.
Clinical and immune profiling for cancer of unknown primary site.
Haratani K, Hayashi H, Takahama T, Nakamura Y, Tomida S, Yoshida T, Chiba Y, Sawada T, Sakai K, Fujita Y, Togashi Y, Tanizaki J, Kawakami H, Ito A, Nishio K, Nakagawa K. Haratani K, et al. Among authors: sakai k. J Immunother Cancer. 2019 Sep 13;7(1):251. doi: 10.1186/s40425-019-0720-z. J Immunother Cancer. 2019. PMID: 31519206 Free PMC article.
Targeting castration-resistant prostate cancer with androgen receptor antisense oligonucleotide therapy.
De Velasco MA, Kura Y, Sakai K, Hatanaka Y, Davies BR, Campbell H, Klein S, Kim Y, MacLeod AR, Sugimoto K, Yoshikawa K, Nishio K, Uemura H. De Velasco MA, et al. Among authors: sakai k. JCI Insight. 2019 Sep 5;4(17):e122688. doi: 10.1172/jci.insight.122688. JCI Insight. 2019. PMID: 31484823 Free PMC article.
An HER3-targeting antibody-drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC.
Yonesaka K, Takegawa N, Watanabe S, Haratani K, Kawakami H, Sakai K, Chiba Y, Maeda N, Kagari T, Hirotani K, Nishio K, Nakagawa K. Yonesaka K, et al. Among authors: sakai k. Oncogene. 2019 Feb;38(9):1398-1409. doi: 10.1038/s41388-018-0517-4. Epub 2018 Oct 9. Oncogene. 2019. PMID: 30302022
Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions.
Yamada M, Komatsu J, Nakamura K, Sakai K, Samuraki-Yokohama M, Nakajima K, Yoshita M. Yamada M, et al. Among authors: sakai k. J Mov Disord. 2020 Jan;13(1):1-10. doi: 10.14802/jmd.19052. Epub 2019 Nov 8. J Mov Disord. 2020. PMID: 31694357 Free PMC article.
Dry weight targeting: The art and science of conventional hemodialysis.
Ohashi Y, Sakai K, Hase H, Joki N. Ohashi Y, et al. Among authors: sakai k. Semin Dial. 2018 Nov;31(6):551-556. doi: 10.1111/sdi.12721. Epub 2018 Jun 6. Semin Dial. 2018. PMID: 29876972 Review.
The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017.
van Dorland HA, Taleghani MM, Sakai K, Friedman KD, George JN, Hrachovinova I, Knöbl PN, von Krogh AS, Schneppenheim R, Aebi-Huber I, Bütikofer L, Largiadèr CR, Cermakova Z, Kokame K, Miyata T, Yagi H, Terrell DR, Vesely SK, Matsumoto M, Lämmle B, Fujimura Y, Kremer Hovinga JA; Hereditary TTP Registry. van Dorland HA, et al. Among authors: sakai k. Haematologica. 2019 Oct;104(10):2107-2115. doi: 10.3324/haematol.2019.216796. Epub 2019 Feb 21. Haematologica. 2019. PMID: 30792199 Free PMC article. Clinical Trial.
Machine learning studies on major brain diseases: 5-year trends of 2014-2018.
Sakai K, Yamada K. Sakai K, et al. Jpn J Radiol. 2019 Jan;37(1):34-72. doi: 10.1007/s11604-018-0794-4. Epub 2018 Nov 29. Jpn J Radiol. 2019. PMID: 30498877 Review.
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Matsuoka H, Iwase S, Miyaji T, Kawaguchi T, Ariyoshi K, Oyamada S, Satomi E, Ishiki H, Hasuo H, Sakuma H, Tokoro A, Shinomiya T, Otani H, Ohtake Y, Tsukuura H, Matsumoto Y, Hasegawa Y, Kataoka Y, Otsuka M, Sakai K, Matsuda Y, Morita T, Koyama A, Yamaguchi T. Matsuoka H, et al. Among authors: sakai k. J Pain Symptom Manage. 2019 Oct;58(4):645-653. doi: 10.1016/j.jpainsymman.2019.06.020. Epub 2019 Jun 26. J Pain Symptom Manage. 2019. PMID: 31254640 Free article.
4,100 results
Jump to page
Feedback